Your browser doesn't support javascript.
loading
Interleukin-6 And Interleukin-10 Polymorphisms In Chronic Lymphoid Leukemia Patients.
Yildiz, Sanem; Bayil Oguzkan, Sibel; Ozaslan, Mehmet; Kizikli, Alperen; Halil Kilic, Ibrahim; Yilmaz, Mehmet.
Afiliação
  • Yildiz S; Department of Medical Services and Techniques, Vocational School of Health Services, University of Gaziantep, Gaziantep, Turkey.
  • Bayil Oguzkan S; Department of Medical Services and Techniques, Vocational School of Health Services, University of Gaziantep, Gaziantep, Turkey.
  • Ozaslan M; Department of Medical Services and Techniques, Vocational School of Health Services, University of Gaziantep, Gaziantep, Turkey.
  • Kizikli A; Department of Medical Services and Techniques, Vocational School of Health Services, University of Gaziantep, Gaziantep, Turkey.
  • Halil Kilic I; Department of Medical Services and Techniques, Vocational School of Health Services, University of Gaziantep, Gaziantep, Turkey.
  • Yilmaz M; Department of Medical Services and Techniques, Vocational School of Health Services, University of Gaziantep, Gaziantep, Turkey.
Asian Pac J Cancer Prev ; 25(2): 461-464, 2024 Feb 01.
Article em En | MEDLINE | ID: mdl-38415531
ABSTRACT

OBJECTIVE:

A major part of the cytokines secreted from the immune system are interleukins (IL) and their main role is to stimulate the immune system cells. Therefore the genotypic effects of IL-6 and IL-10 on the immune system in CLL were investigated in the study.

METHOD:

For this purpose 100 patients diagnosed with CLL and 70 healthy individuals with no cancer history were included in the study. Polymorphisms at IL10 and IL 6 promoter regions (1082 A\G and 819 C\T) and IL6 (174 G\C) polymorphisms were analyzed with RT-PCR. Genotype and allele frequencies were directly calculated.

RESULT:

In 100 CLL patients, 45 wild type AA, 40 AG and 15 mutant type GG genotypes were found for the IL 10 1082 A\G region. Genotypic distribution of IL10 819 C\T region was determined as CC, BT and TT genotypes in 37, 50 and 13 patients, respectively. In IL 6 174 G\C region, GG, GC and CC genotypes were determined in 62, 30 and 8 patients, respectively. There is no statistically significant difference between the CLL patients and control groups in terms of IL10 1082 A\G, 819 C\T and IL 6 174 G/C regions (p> 0.05). As a result of the allele frequency calculation of the IL 10 1082 region, the values obtained were A (0.65), G (0.35) for the patient group and (0.61) and G (0.31) for the control group. 819 region allele frequencies were C (0.57) and T (0.33) in the patient group and C (0.48) and T (0.32) in the control group. The IL6 174 region was calculated as G (0.82), C (0.28) in the patient group and G (0.63), C (0.23) in the control group. Given the number of patients within the limits of this study, IL 10 and IL 6 genotype frequencies do not seem to be statistically related to CLL patients.

CONCLUSION:

Mutant alleles of all interleukin SNPs were determined at a higher frequency in the patient group as compared to the control group. Therefore, a potential correlation between the SNPs of these interleukins and CLL can be determined in future studies with a higher number of samples.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Interleucina-6 Limite: Humans Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Interleucina-6 Limite: Humans Idioma: En Revista: Asian Pac J Cancer Prev Assunto da revista: NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Turquia